Green Cross Plans to Launch Mass Production of Human Placenta Injectable Preparations

Published: 2005-02-28 06:58:00
Updated: 2005-02-28 06:58:00
Green Cross Holdings and Japan Bioproducts Industry Co. Ltd (Tokyo, Japan) recently agreed to form a joint venture to launch a domestic mass production of human placenta injectable preparations, with an expected start date of May.

The formation of the joint venture, known as GC Japan Bio Corp....

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.